MétaCan
Menu
Back to cohort
Record W4220762197 · doi:10.1186/s13195-022-00962-4

Challenges at the APOE locus: a robust quality control approach for accurate APOE genotyping

2022· article· en· W4220762197 on OpenAlexfundno aff
Michaël E. Belloy, Sarah J. Eger, Yann Le Guen, Vincent Damotte, Shahzad Ahmad, M. Arfan Ikram, Alfredo Ramı́rez, Anthoula Tsolaki, Giacomina Rossi, Iris E. Jansen, Itziar de Rojas, Kayenat Parveen, Kristel Sleegers, Martin Ingelsson, Mikko Hiltunen, Najaf Amin, Ole A. Andreassen, Pascual Sánchez‐Juan, Patrick G. Kehoe, Philippe Amouyel, Rebecca Sims, Ruth Frikke‐Schmidt, Wiesje M. van der Flier, Jean‐Charles Lambert, Zihuai He, Summer S. Han, Valerio Napolioni, Michael D. Greicius

Bibliographic record

VenueAlzheimer s Research & Therapy · 2022
Typearticle
Languageen
FieldMedicine
TopicAlzheimer's disease research and treatments
Canadian institutionsnot available
FundersNational Center for Research ResourcesNational Institute of Biomedical Imaging and BioengineeringNational Institute of Neurological Disorders and StrokeNational Institute of Diabetes and Digestive and Kidney DiseasesNational Human Genome Research InstituteNational Institute of Mental HealthNational Heart, Lung, and Blood InstituteNational Institute on AgingCenter for Innovative MedicineFundação para a Ciência e a TecnologiaNational Health and Medical Research CouncilEconomic and Social Research CouncilMedical Research CouncilGenentechNational Institutes of HealthFondation pour la Recherche sur AlzheimerAmsterdam NeuroscienceSeinäjoen KeskussairaalaSorbonne UniversitéAssociazione Italiana Ricerca AlzheimerUK Dementia Research InstituteLudwig Boltzmann GesellschaftDemensfondenIXICOStichting ALS NederlandNederlandse Federatie van Universitair Medische CentraAlzheimer NederlandUniversità degli Studi di CamerinoInstituto de Investigación Marqués de ValdecillaStichting DioraphteFondazione I.R.C.C.S. Istituto Neurologico Carlo BestaMutuelle Générale de l'Education NationaleUniversität zu KölnAgence Française de Sécurité Sanitaire des Produits de SantéFundación Salud 2000Aristotle University of ThessalonikiSahlgrenska UniversitetssjukhusetDeutsches Zentrum für Neurodegenerative ErkrankungenSouth London and Maudsley NHS Foundation TrustRigshospitaletNovo NordiskVetenskapsrådetBanco Bilbao Vizcaya ArgentariaCanadian Institutes of Health ResearchEuropean CommissionKnut och Alice Wallenbergs StiftelseAmsterdam University Medical CentersUniversité de LilleKarolinska InstitutetJuho Vainion SäätiöHealth~HollandMinisterstvo Zdravotnictví Ceské RepublikyFonds Wetenschappelijk OnderzoekSuomen KulttuurirahastoUniversity College London Hospitals NHS Foundation TrustMinisterio de Economía y CompetitividadErasmus Medisch CentrumUniverzita Karlova v PrazeGeneralitat de CatalunyaBundesministerium für Bildung und ForschungUniversitetet i OsloUniversity of NottinghamLundbeckfondenAXA Research FundVrije Universiteit AmsterdamStockholms Läns LandstingSchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen ForschungMinistero della SaluteH. Lundbeck A/SEuropean Federation of Pharmaceutical Industries and AssociationsInstitut National de la Santé et de la Recherche MédicaleNational Institute on Minority Health and Health DisparitiesUniversität HeidelbergNorth Bristol NHS TrustNederlandse Organisatie voor Wetenschappelijk OnderzoekKing's College LondonGentofte HospitalDeutsche ForschungsgemeinschaftNational Research FoundationCardiff UniversityUniversity of BristolSocialdepartementetBioClinicaNewcastle UniversityUniversity of OxfordUniversitat de BarcelonaGrifolsServierAcademy of FinlandHigher Education Funding Council for WalesNational Institute for Health and Care ResearchDipartimenti di EccellenzaDevelopment of Innovative Strategies for a Transdisciplinary approach to ALZheimer's diseaseMinistero dell’Istruzione, dell’Università e della RicercaFundación BBVAAlzheimer's AssociationMeso Scale DiagnosticsYrjö Jahnssonin SäätiöNorthern California Institute for Research and EducationTranslational Genomics Research InstituteSigrid Juséliuksen SäätiöStichting MS ResearchUniversity of SouthamptonCentro de Investigación Biomédica en Red sobre Enfermedades NeurodegenerativasAlzheimer's SocietyUniversiteit AntwerpenMinisterstvo Školství, Mládeže a TělovýchovyNational Institute for Social Care and Health ResearchMotor Neurone Disease AssociationNovartis Pharmaceuticals CorporationZonMwUniversity of CambridgeUniversity of PittsburghUniversity of MiamiEU Joint Programme – Neurodegenerative Disease ResearchUniversity of WashingtonPfizerWellcome TrustAgence Nationale de la RechercheUniformed Services University of the Health SciencesBiogenUniversity of PennsylvaniaFondation de FranceEisaiSanofiVlaamse regeringBroad InstituteUniversidade de AveiroUniversity of Southern CaliforniaFoundation for the National Institutes of HealthUppsala UniversitetRush UniversityF. Hoffmann-La RocheVanderbilt UniversityInstituto de Salud Carlos IIIUniversidad de CantabriaNational Cancer InstituteEuropean Regional Development FundAlzheimer's Research TrustHersenstichtingU.S. Department of DefenseEli Lilly and CompanyItä-Suomen YliopistoIllinois Department of Public HealthGlaxoSmithKlineBristol-Myers SquibbAlzheimer's Disease Neuroimaging InitiativeFondation pour la Recherche Médicale
KeywordsGenotypingApolipoprotein ELocus (genetics)MedicineGeneticsComputational biologyData scienceBiologyComputer scienceGenotypeInternal medicineGeneDisease

Abstract

fetched live from OpenAlex

BACKGROUND: Genetic variants within the APOE locus may modulate Alzheimer's disease (AD) risk independently or in conjunction with APOE*2/3/4 genotypes. Identifying such variants and mechanisms would importantly advance our understanding of APOE pathophysiology and provide critical guidance for AD therapies aimed at APOE. The APOE locus however remains relatively poorly understood in AD, owing to multiple challenges that include its complex linkage structure and uncertainty in APOE*2/3/4 genotype quality. Here, we present a novel APOE*2/3/4 filtering approach and showcase its relevance on AD risk association analyses for the rs439401 variant, which is located 1801 base pairs downstream of APOE and has been associated with a potential regulatory effect on APOE. METHODS: We used thirty-two AD-related cohorts, with genetic data from various high-density single-nucleotide polymorphism microarrays, whole-genome sequencing, and whole-exome sequencing. Study participants were filtered to be ages 60 and older, non-Hispanic, of European ancestry, and diagnosed as cognitively normal or AD (n = 65,701). Primary analyses investigated AD risk in APOE*4/4 carriers. Additional supporting analyses were performed in APOE*3/4 and 3/3 strata. Outcomes were compared under two different APOE*2/3/4 filtering approaches. RESULTS: Using more conventional APOE*2/3/4 filtering criteria (approach 1), we showed that, when in-phase with APOE*4, rs439401 was variably associated with protective effects on AD case-control status. However, when applying a novel filter that increases the certainty of the APOE*2/3/4 genotypes by applying more stringent criteria for concordance between the provided APOE genotype and imputed APOE genotype (approach 2), we observed that all significant effects were lost. CONCLUSIONS: We showed that careful consideration of APOE genotype and appropriate sample filtering were crucial to robustly interrogate the role of the APOE locus on AD risk. Our study presents a novel APOE filtering approach and provides important guidelines for research into the APOE locus, as well as for elucidating genetic interaction effects with APOE*2/3/4.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.006
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow), Science and technology studies
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.934
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0060.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.001
Science and technology studies0.0030.001
Scholarly communication0.0000.000
Open science0.0010.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.368
GPT teacher head0.449
Teacher spread0.080 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designNot applicable
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations20
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s Research & TherapySame topicAlzheimer's disease research and treatmentsFrench-language works237,207